Recombinant multi-species RAD51C protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis

Genemedi produces recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine RAD51C protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis.
This gene is a member of the RAD51 family. RAD51 family members are highly similar to bacterial RecA and Saccharomyces cerevisiae Rad51 and are known to be involved in the homologous recombination and repair of DNA. This protein can interact with other RAD51 paralogs and is reported to be important for Holliday junction resolution. Mutations in this gene are associated with Fanconi anemia-like syndrome. This gene is one of four localized to a region of chromosome 17q23 where amplification occurs frequently in breast tumors. Overexpression of the four genes during amplification has been observed and suggests a possible role in tumor progression. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Jul 2013]
The Alternative Names of target: BROVCA3,DNA repair protein RAD51 homolog 3,FANCO,R51H3,RAD51 homolog C,RAD51-like protein 2,RAD51C,RAD51L2,RGD1563765,Rad51c,Rad51l2

Target products collectionGo to RAD51C products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)

pdfMSDSpdfCOApdfDatasheet

Product information

Catalog No. Product Name Species Reactivity
GM-Tg-hg-IP2689-Ag-1/ GM-Tg-hg-IP2689-Ag-2 Human RAD51C protein Human
GM-Tg-rg-IP2689-Ag-1/ GM-Tg-rg-IP2689-Ag-2 Rat RAD51C protein Rat
GM-Tg-mg-IP2689-Ag-1/ GM-Tg-mg-IP2689-Ag-2 Mouse RAD51C protein Mouse
GM-Tg-cynog-IP2689-Ag-1/ GM-Tg-cynog-IP2689-Ag-2 Cynomolgus/Rhesus macaque RAD51C protein Cynomolgus/ Rhesus macaque
GM-Tg-felg-IP2689-Ag-1/ GM-Tg-felg-IP2689-Ag-2 Feline RAD51C protein Feline
GM-Tg-cang-IP2689-Ag-1/ GM-Tg-cang-IP2689-Ag-2 Canine RAD51C protein Canine
GM-Tg-bovg-IP2689-Ag-1/ GM-Tg-bovg-IP2689-Ag-2 Bovine RAD51C protein Bovine
GM-Tg-equg-IP2689-Ag-1/ GM-Tg-equg-IP2689-Ag-2 Equine RAD51C protein Equine

Size： 1mg | 10mg | 100mg



Product Description

Catalog No. GM-Tg-hg-IP2689-Ag-1/ GM-Tg-hg-IP2689-Ag-2; GM-Tg-rg-IP2689-Ag-1/ GM-Tg-rg-IP2689-Ag-2;
GM-Tg-mg-IP2689-Ag-1/ GM-Tg-mg-IP2689-Ag-2; GM-Tg-cynog-IP2689-Ag-1/ GM-Tg-cynog-IP2689-Ag-2;
GM-Tg-felg-IP2689-Ag-1/ GM-Tg-felg-IP2689-Ag-2; GM-Tg-cang-IP2689-Ag-1/ GM-Tg-cang-IP2689-Ag-2;
GM-Tg-bovg-IP2689-Ag-1/ GM-Tg-bovg-IP2689-Ag-2; GM-Tg-equg-IP2689-Ag-1/ GM-Tg-equg-IP2689-Ag-2
Products Name RAD51C protein
Species Human, Cynomolgus/ Rhesus macaque, rat, mouse, Feline, Canine, Bovine, Equine
Target Name RAD51C
Protein Sub-location Introcelluar Protein
Isotypes Recombinant protein
Expression platform Mammalian cell
Bioactivity validation Affintiy&bioactivity validated by ELISA, cell culture validated.
Tag His
Products description Recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine RAD51C protein was expressed in mammalian cell expression system and is expressed with 6 HIS tag at the C-terminus for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic).
Purity Purity: ≥95% (SDS-PAGE)
Application In vitro study, in vivo study, benchmark, positive control for the diagnosis. Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference






    About Gmab

    GDU
    GDU

    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.
    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.